A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinethazone
Barnidipine
Aliskiren may increase the antihypertensive activities of Barnidipine.
Quinethazone
Lacidipine
Aliskiren may increase the hypotensive activities of Lacidipine.
Quinethazone
Sodium phosphate, monobasic
The risk or severity of nephrotoxicity can be increased when Sodium phosphate, monobasic is combined with Aliskiren.
Quinethazone
Dexniguldipine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Dexniguldipine.
Quinethazone
Tetrandrine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Tetrandrine.
Quinethazone
Lomerizine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Lomerizine.
Quinethazone
Emopamil
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Emopamil.
Quinethazone
Dexverapamil
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Dexverapamil.
Quinethazone
Fish oil
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Fish oil.
Quinethazone
WIN 55212-2
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with WIN 55212-2.
Quinethazone
Caroverine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Caroverine.
Quinethazone
Penfluridol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Penfluridol.
Quinethazone
Tertatolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Tertatolol.
Quinethazone
Lidoflazine
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Lidoflazine.
Quinethazone
Epanolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Epanolol.
Quinethazone
Terodiline
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Terodiline.
Quinethazone
Mepindolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Mepindolol.
Quinethazone
Cloranolol
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Cloranolol.
Quinethazone
Otilonium
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Otilonium.
Quinethazone
Bencyclane
The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Bencyclane.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3